Chemoradiotherapy for neurohypophyseal immature teratoma
We performed chemoradiotherapy for two patients (aged 6 and 33 years)with neurohypophyseal immature teratoma. The patients received total doses of 40 to 50.6 Gy with concurrent carboplatin and etoposide. In both cases, neurological symptoms improved. Both patients are still alive and remain free fro...
Gespeichert in:
| Veröffentlicht in: | Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 2005-04, Vol.65 (2), p.127 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 127 |
| container_title | Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica |
| container_volume | 65 |
| creator | Monzen, Yoshio Okimoto, Tomoaki Imafuku, Yoshihiro Yamatogi, Shigenari Turudome, Takako Kimura, Shoujiro Kiya, Katuzo Fukuhara, Toshiyuki |
| description | We performed chemoradiotherapy for two patients (aged 6 and 33 years)with neurohypophyseal immature teratoma. The patients received total doses of 40 to 50.6 Gy with concurrent carboplatin and etoposide. In both cases, neurological symptoms improved. Both patients are still alive and remain free from local recurrence and distant metastasis 92 months and 62 months, respectively, after the completion of chemoradiotherapy. No late complications were observed. Chemoradiotherapy is extremely effective in the treatment of neurohypophyseal immature teratoma. |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_15920974</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15920974</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-e8d1df104566afbb2f51e1c4d11dc88d6cdb5a6772d62c6c4eca7026f56b7db03</originalsourceid><addsrcrecordid>eNo1j0tqwzAUALVoaUKaKwRfwCDJkiwvi-kPAt206_Ck94QNUSRkeeHbt9B2NZthYO7YnnNlW66k3bHjssyOc6ls14nhge2EHiQferVndpwopgI4pzpRgbw1IZXmRmtJ05ZTnraF4NrMMUJdCzX1R6opwiO7D3Bd6PjHA_t6ef4c39rzx-v7-HRus5CqtmRRYBBcaWMgOCeDFiS8QiHQW4vGo9Ng-l6ikd54RR56Lk3QxvXoeHdgp99uXl0kvOQyRyjb5X-h-was3EQv</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chemoradiotherapy for neurohypophyseal immature teratoma</title><source>Freely Accessible Japanese Titles (ERDB Project)</source><source>MEDLINE</source><creator>Monzen, Yoshio ; Okimoto, Tomoaki ; Imafuku, Yoshihiro ; Yamatogi, Shigenari ; Turudome, Takako ; Kimura, Shoujiro ; Kiya, Katuzo ; Fukuhara, Toshiyuki</creator><creatorcontrib>Monzen, Yoshio ; Okimoto, Tomoaki ; Imafuku, Yoshihiro ; Yamatogi, Shigenari ; Turudome, Takako ; Kimura, Shoujiro ; Kiya, Katuzo ; Fukuhara, Toshiyuki</creatorcontrib><description>We performed chemoradiotherapy for two patients (aged 6 and 33 years)with neurohypophyseal immature teratoma. The patients received total doses of 40 to 50.6 Gy with concurrent carboplatin and etoposide. In both cases, neurological symptoms improved. Both patients are still alive and remain free from local recurrence and distant metastasis 92 months and 62 months, respectively, after the completion of chemoradiotherapy. No late complications were observed. Chemoradiotherapy is extremely effective in the treatment of neurohypophyseal immature teratoma.</description><identifier>ISSN: 0048-0428</identifier><identifier>PMID: 15920974</identifier><language>jpn</language><publisher>Japan</publisher><subject>Adult ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Carboplatin - administration & dosage ; Child ; Drug Administration Schedule ; Etoposide - administration & dosage ; Female ; Humans ; Pituitary Neoplasms - drug therapy ; Pituitary Neoplasms - radiotherapy ; Radiotherapy Dosage ; Teratoma - drug therapy ; Teratoma - radiotherapy</subject><ispartof>Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2005-04, Vol.65 (2), p.127</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15920974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Monzen, Yoshio</creatorcontrib><creatorcontrib>Okimoto, Tomoaki</creatorcontrib><creatorcontrib>Imafuku, Yoshihiro</creatorcontrib><creatorcontrib>Yamatogi, Shigenari</creatorcontrib><creatorcontrib>Turudome, Takako</creatorcontrib><creatorcontrib>Kimura, Shoujiro</creatorcontrib><creatorcontrib>Kiya, Katuzo</creatorcontrib><creatorcontrib>Fukuhara, Toshiyuki</creatorcontrib><title>Chemoradiotherapy for neurohypophyseal immature teratoma</title><title>Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica</title><addtitle>Nihon Igaku Hoshasen Gakkai Zasshi</addtitle><description>We performed chemoradiotherapy for two patients (aged 6 and 33 years)with neurohypophyseal immature teratoma. The patients received total doses of 40 to 50.6 Gy with concurrent carboplatin and etoposide. In both cases, neurological symptoms improved. Both patients are still alive and remain free from local recurrence and distant metastasis 92 months and 62 months, respectively, after the completion of chemoradiotherapy. No late complications were observed. Chemoradiotherapy is extremely effective in the treatment of neurohypophyseal immature teratoma.</description><subject>Adult</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Carboplatin - administration & dosage</subject><subject>Child</subject><subject>Drug Administration Schedule</subject><subject>Etoposide - administration & dosage</subject><subject>Female</subject><subject>Humans</subject><subject>Pituitary Neoplasms - drug therapy</subject><subject>Pituitary Neoplasms - radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Teratoma - drug therapy</subject><subject>Teratoma - radiotherapy</subject><issn>0048-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tqwzAUALVoaUKaKwRfwCDJkiwvi-kPAt206_Ck94QNUSRkeeHbt9B2NZthYO7YnnNlW66k3bHjssyOc6ls14nhge2EHiQferVndpwopgI4pzpRgbw1IZXmRmtJ05ZTnraF4NrMMUJdCzX1R6opwiO7D3Bd6PjHA_t6ef4c39rzx-v7-HRus5CqtmRRYBBcaWMgOCeDFiS8QiHQW4vGo9Ng-l6ikd54RR56Lk3QxvXoeHdgp99uXl0kvOQyRyjb5X-h-was3EQv</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Monzen, Yoshio</creator><creator>Okimoto, Tomoaki</creator><creator>Imafuku, Yoshihiro</creator><creator>Yamatogi, Shigenari</creator><creator>Turudome, Takako</creator><creator>Kimura, Shoujiro</creator><creator>Kiya, Katuzo</creator><creator>Fukuhara, Toshiyuki</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200504</creationdate><title>Chemoradiotherapy for neurohypophyseal immature teratoma</title><author>Monzen, Yoshio ; Okimoto, Tomoaki ; Imafuku, Yoshihiro ; Yamatogi, Shigenari ; Turudome, Takako ; Kimura, Shoujiro ; Kiya, Katuzo ; Fukuhara, Toshiyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-e8d1df104566afbb2f51e1c4d11dc88d6cdb5a6772d62c6c4eca7026f56b7db03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Carboplatin - administration & dosage</topic><topic>Child</topic><topic>Drug Administration Schedule</topic><topic>Etoposide - administration & dosage</topic><topic>Female</topic><topic>Humans</topic><topic>Pituitary Neoplasms - drug therapy</topic><topic>Pituitary Neoplasms - radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Teratoma - drug therapy</topic><topic>Teratoma - radiotherapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Monzen, Yoshio</creatorcontrib><creatorcontrib>Okimoto, Tomoaki</creatorcontrib><creatorcontrib>Imafuku, Yoshihiro</creatorcontrib><creatorcontrib>Yamatogi, Shigenari</creatorcontrib><creatorcontrib>Turudome, Takako</creatorcontrib><creatorcontrib>Kimura, Shoujiro</creatorcontrib><creatorcontrib>Kiya, Katuzo</creatorcontrib><creatorcontrib>Fukuhara, Toshiyuki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Monzen, Yoshio</au><au>Okimoto, Tomoaki</au><au>Imafuku, Yoshihiro</au><au>Yamatogi, Shigenari</au><au>Turudome, Takako</au><au>Kimura, Shoujiro</au><au>Kiya, Katuzo</au><au>Fukuhara, Toshiyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemoradiotherapy for neurohypophyseal immature teratoma</atitle><jtitle>Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica</jtitle><addtitle>Nihon Igaku Hoshasen Gakkai Zasshi</addtitle><date>2005-04</date><risdate>2005</risdate><volume>65</volume><issue>2</issue><spage>127</spage><pages>127-</pages><issn>0048-0428</issn><abstract>We performed chemoradiotherapy for two patients (aged 6 and 33 years)with neurohypophyseal immature teratoma. The patients received total doses of 40 to 50.6 Gy with concurrent carboplatin and etoposide. In both cases, neurological symptoms improved. Both patients are still alive and remain free from local recurrence and distant metastasis 92 months and 62 months, respectively, after the completion of chemoradiotherapy. No late complications were observed. Chemoradiotherapy is extremely effective in the treatment of neurohypophyseal immature teratoma.</abstract><cop>Japan</cop><pmid>15920974</pmid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0048-0428 |
| ispartof | Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2005-04, Vol.65 (2), p.127 |
| issn | 0048-0428 |
| language | jpn |
| recordid | cdi_pubmed_primary_15920974 |
| source | Freely Accessible Japanese Titles (ERDB Project); MEDLINE |
| subjects | Adult Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carboplatin - administration & dosage Child Drug Administration Schedule Etoposide - administration & dosage Female Humans Pituitary Neoplasms - drug therapy Pituitary Neoplasms - radiotherapy Radiotherapy Dosage Teratoma - drug therapy Teratoma - radiotherapy |
| title | Chemoradiotherapy for neurohypophyseal immature teratoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T14%3A59%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemoradiotherapy%20for%20neurohypophyseal%20immature%20teratoma&rft.jtitle=Nihon%20Igaku%20Hoshasen%20Gakkai%20zasshi.%20Nippon%20acta%20radiologica&rft.au=Monzen,%20Yoshio&rft.date=2005-04&rft.volume=65&rft.issue=2&rft.spage=127&rft.pages=127-&rft.issn=0048-0428&rft_id=info:doi/&rft_dat=%3Cpubmed%3E15920974%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15920974&rfr_iscdi=true |